Projects per year
We undertake clinical trials and clinical research in areas of Respiratory Medicine and Rhinology and ENT Surgery, with an emphasis on Asthma, Interstitial Lung Disease and disorders altering the sense of smell. Currently the group co-ordinates three National Clinical Trials with funding totalling £6.3M. The ARRISA-UK project is investigating the role of risk registers and their implementation in clinical practice, the EME-TIPAC study is investigating the efficacy of antibiotic therapy in people with idiopathic pulmonary fibrosis and the MACRO study is evaluating the effects of macrolide treatment in people with chronic rhino sinusitis. We also undertake studies looking at epidemiology, health related quality of life, exercise, and biomarkers, in a range of conditions affecting the respiratory tract in its widest sense.
Our key areas of research are:
- Interstitial Lung Disease
- Rhinitis and rhino sinusitis
- Exercise and activity
Dive into details
Select a country/territory to view shared publications and projects
1/10/19 → 30/09/24
A discrete choice experiment to derive health utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiencySmith, A. B., Hanbury, A., Whitty, J. & Buesch, K., 12 May 2021, In : Patient Related Outcome Measures. 12, p. 97—106 10 p.
Research output: Contribution to journal › ArticleOpen AccessFile3 Downloads (Pure)
Admission avoidance in acute epistaxis: a prospective national audit during the initial peak of the COVID‐19 pandemicHardman, J. C. & INTEGRATE, The UK ENT Trainee Research Collaborative, May 2021, In : Clinical Otolaryngology. 46, 3, p. 577-586 10 p.
Research output: Contribution to journal › Article2 Citations (Scopus)
Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemicINTEGRATE, The UK ENT Trainee Research Collaborative, Mar 2021, In : Clinical Otolaryngology. 46, 2, p. 363-372 10 p.
Research output: Contribution to journal › ArticleOpen AccessFile5 Downloads (Pure)